Nautilus Biotechnolgy (NAUT) Stock Analysis

What Nautilus Biotechnolgy does

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrument, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libraries onto a flow cell and to process labeled multi-affinity reagent binding and imaging cycles rapidly to decode and quantify the proteins present in biological samples. In addition, the company offers single-molecule library preparation kits, flow cells, affinity reagents, and instrument run buffers to perform multi-cycle analysis runs. It has a research collaboration agreement Genentech, Buck Institute, Allen Institute, Cornell University and the Qatar Foundation, and Michael J. Fox Foundation. Nautilus Biotechnology, Inc. was founded in 2016 and is headquartered in Seattle, Washington.

Key metrics

ETFs linked to NAUT

Broad-market and Healthcare sector ETFs an investor holding Nautilus Biotechnolgy is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how NAUT fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Nautilus Biotechnolgy?

Nautilus Biotechnolgy trades under the ticker NAUT on NASDAQ.

Which exchange is NAUT listed on?

NAUT is listed on NASDAQ.

What sector does Nautilus Biotechnolgy operate in?

Nautilus Biotechnolgy is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze NAUT in a portfolio?

PortView shows NAUT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.